Pdt Partners, LLC Ironwood Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $272,411 - $330,694	-25,675 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $278,830 - $358,166	25,675 New	25,675 $299,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $1.68 Million - $2.26 Million	-185,517 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $467,327 - $558,297	-51,983 Reduced 21.89%	185,517 $1.67 Million
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $176,438 - $231,068	-19,304 Reduced 7.52%	237,500 $2.45 Million

Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $301,981 - $493,095	-35,196 Reduced 12.05%	256,804 $2.59 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $269,574 - $459,130	32,795 Added 12.65%	292,000 $3.89 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $855,606 - $1.09 Million	99,605 Added 62.41%	259,205 $2.23 Million
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $1.32 Million - $2.03 Million	159,600 New	159,600 $2.16 Million

296

170M

27.1M

2.28M

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $999M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.